Hansa Biopharma’s SEK 415.9 Million Directed Share Issue

Vinge has advised Hansa Biopharma on the deal.Hansa Biopharma announced directed share issue through which the company raises proceeds of SEK 415.9 million before transaction costs. Through…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here